Keyphrases
Total Nasal Symptom Score
44%
Persistent Allergic Rhinitis
33%
Radiofrequency Turbinate Reduction
33%
Chronic Rhinitis
33%
Intranasal Antihistamines
33%
Nasal Symptoms
33%
Nonallergic Rhinitis
33%
Intranasal Steroids
33%
Sleep Disorders
33%
Randomized Clinical Trial
33%
Intervention Group
33%
Perennial Allergic Rhinitis
33%
Sleep Disturbance
33%
Mometasone Furoate Nasal Spray
33%
Sleep Architecture
33%
Clinical Efficacy
33%
Tolerability
33%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
25%
Matrix metalloproteinase-9 (MMP-9)
25%
Nasal Spray
19%
Mometasone Furoate
19%
Nasal Obstruction Symptom Evaluation Scale
16%
Epworth Sleepiness Scale
16%
Evaluation Score
16%
Pittsburgh Sleep Quality Index
16%
Inflammatory Mediators
16%
Clinical Improvement
16%
Tropical Countries
14%
Allergic Rhinitis
11%
Polysomnography
11%
Daytime Sleepiness
11%
Index Score
11%
Nasal Congestion Score
9%
Moderate to Severe
9%
Mean Reduction
9%
Remodeling Process
8%
Turbinates
8%
Peak Nasal Inspiratory Flow
8%
Nasal Secretion
8%
Nasal Biopsy
8%
Visual Analog Scale
8%
Plasminogen Activator inhibitor-1 (PAI-1)
8%
Long Follow-up
8%
Pharmacotherapy
8%
Large Sample Size
8%
Immunohistochemistry
8%
T-test
8%
Initial Treatment
8%
Chi-square Test
8%
Clinical Response
8%
Pharmacology, Toxicology and Pharmaceutical Science
Vasomotor Rhinitis
100%
Perennial Rhinitis
66%
Sleep Disorder
33%
Tolerability
33%
Mometasone Furoate
33%
Randomized Clinical Trial
33%
Tissue Inhibitor of Metalloproteinase
33%
Gelatinase B
33%
Chronic Rhinitis
33%
Nasal Spray
33%
Antihistaminic Agent
33%
Nose Obstruction
23%
Somnolence
14%
Daytime Somnolence
14%
Enzyme-Linked Immunosorbent Assay
11%
Interleukin 5
11%
Pharmacotherapy
11%
Allergic Rhinitis
9%
Medicine and Dentistry
Vasomotor Rhinitis
66%
Metalloprotease Inhibitor
33%
Turbinate
33%
Chronic Rhinitis
33%
Randomized Clinical Trial
33%
Sleep Disorder
33%
Gelatinase B
33%
Histamine Antagonist
33%
Inflammatory Mediator
22%
Epworth Sleepiness Scale
14%
Nasal Congestion
14%
Sleep Quality
14%
Nasal Biopsy
11%
Nose Secretion
11%
Peak Nasal Inspiratory Flow
11%
Enzyme Linked Immunosorbent Assay
11%
Immunohistochemistry
11%
Visual Analog Scale
11%
Student T Test
11%
Adjuvant Therapy
11%
Chi Square Test
11%
Drug Therapy
11%
Plasminogen Activator Inhibitor-1
11%
Interleukin 5
11%
Daytime Somnolence
9%
Allergic Rhinitis
9%
Polysomnography
9%
